Daniel Muñoz-Espín studied Biology and Molecular Biology at the Autonomous University of Madrid in Spain, where he also completed his PhD with cum laude honours within the Viral DNA Replication Group at the Centre of Molecular Biology Severo Ochoa (CMBSO), under the supervision of Dr Margarita Salas. During his PhD he also worked at Sir William Dunn School of Pathology (University of Oxford, UK) as a visiting student. He was then awarded an I3P Fellowship followed by a Spanish National Research Council Fellowship to conduct postdoctoral research on DNA replication, resulting in several first- and/or corresponding authored papers (including 5 PNAS, The EMBO Journal and 3 Journal of Biological Chemistry). Based on his research, a patent was filed on a novel gene delivery system to Sygnis AG Pharma (2013). He then moved to the Spanish National Cancer Research Centre (CNIO) to Dr Manuel Serrano’s group, where his main work, published in Cell and Nature Reviews Molecular Cell Biology, culminated with two awarded grants: a “Ramon y Cajal Programme Senior Grant” and a “National Programme Grant for Researched Aimed at the H2020 Societal Changes”.

In 2016, Dr Muñoz-Espín joined the Department of Oncology at the University of Cambridge as a Senior Research Associate and Principal Investigator as part of the Cancer Early Detection Programme of the Cambridge Cancer Centre. Some of his current funding sources include an MRC New Investigator Research Grant, a Royal Society Research Grant, a CRUK-OHSU Early Detection Grant, and a CRUK Programme Foundation Award. The experimental outputs of Muñoz-Espín´s lab have been published in EMBO Molecular Medicine and Aging Cell, among other peer-reviewed journals. Dr Muñoz-Espín is Co-Director of the CRUK Cambridge Centre Thoracic Cancer Programme, member of the Cambridge Philosophical Society and member of the International Cellular Senescence Association Steering Committee.